Respond to prefers-color-scheme dark in app web views

Follow section front redirects in Spectrum

Enable NLP source in PCS for load testing

Switch off the News Alerts Survey Widget when we have enough responses

Poll to determine if new LUF updates are available

Allows the winning A/B test variant to be turned on without Spectrum deployment

Show infinite scrolling sections in Assembler MultiView

Show option for NLP article summaries in Action Bar

A general feature flag for Recipe Features that aren't yet released

Feature flag for media team features that aren't yet released

Use new Orca video player for preroll plugin in Spectrum

Show the snow tracker (instead of the heat tracker) on Spectrum

Cat climbed into Amazon return box, found alive 630 miles away

Brave Little Hunter is free: Baby orca escapes lagoon for open seas

I learned to heal my sadness by cradling dying chickens 

Chinese EVs are good for the world. Biden says they’re bad for America. 

Why the Solomon Islands election matters to China and the U.S.

Biden calls ally Japan ‘xenophobic’ like China, Russia, at campaign event

That time football legend, rig-driving eligible bachelor Biden was arrested

Trump and allies say Biden pays rent for ‘illegals’ in Michigan. Not true.

Eighty percent of Ukraine-Israel bill will be spent in U.S. or by U.S. military

Miss Manners: Offering my bedroom to guests

Ask Amy: My wife’s sister confessed her feelings for me

Carolyn Hax: Will request for a postnup offend much younger wife?

NASA moon capsule suffered extensive damage during 2022 test flight

Russian state media ramping up English, Spanish presence on TikTok, study finds

Apple is behind in AI and killed its self-driving car project. What’s next?

Wait, what is Stephen A. Smith talking about? Find out with our quiz.

Stephen A. Smith would like even more of your attention

Local sports networks go dark mid-game amid dispute with Comcast 

The 6 best things to do with kids in the D.C. area this weekend 

The 33 best things to do in D.C. this weekend and next week

Trevor Williams’s escape act helps Nationals blank Rangers 

World Press Freedom Day, 2024

How Trump convinces Republicans to adopt extreme views

Campuses are grappling with the Gaza war. So are our columnists.

Young Georgians want to be part of Europe. Their government is in the way.

On Press Freedom Day, little to celebrate for Hong Kong’s journalists

Taxes are inevitable. Paying to prepare them doesn’t have to be.

What’s the best bus to New York? We tested 5 for comfort and value.

You asked: Do I need a passport for my cruise?

Adaptive equipment is making national parks more inclusive

This masterpiece ‘Birth of Venus’ probably isn’t of Venus at all

The beginner’s illustrated guide to watching an F1 race

US President Joe Biden Departure

Vice President Biden, who led the Obama administration’s “cancer moonshot” initiative, will create a nonprofit organization to grapple with a broad range of cancer issues, including the high cost of cancer drugs, he said in an interview Wednesday.

“I’m going to begin a national conversation and get Congress and advocacy groups in to make sure these treatments are accessible for everyone, including these vulnerable underserved populations, and that we have a more rational way of paying for them while promoting innovation,” Biden said.

The new nonprofit group, Biden said, will focus on many “moonshot” issues, including the need to knock down “silos” in cancer research and share research data and medical records more widely, boosting participation in clinical trials, and finding new ways to improve treatment provided by community oncologists. He said he also wanted to work on reducing racial disparities in diagnosis and treatment.

The vice president, who lost his son, Beau, to brain cancer in May 2015, didn’t focus much on drug prices during his almost year-long sprint to accelerate progress against cancer. Part of the reason, he said, was that there were many other issues to pursue. But another reason was that Democratic presidential nominee Hillary Clinton, a harsh critic of the pharmaceutical industry, had asked him to continue running the moonshot effort after he left the White House, and drug costs “was one of the points on the agenda,” he said.

Now, Biden said, he is getting strong encouragement from throughout the cancer community to grapple with the pricing issue. “The researchers, the insurers, all of the major cancer centers . . . want me to pursue it.” He added that Greg Simon, executive director of the White House Moonshot Task Force, recently met with the pharmaceutical company officials. “They all realize they have a problem,” the vice president said.

In December, President-elect Donald Trump also spoke out against pharmaceutical-industry price hikes. “I'm going to bring down drug prices,” he told Time magazine.

The new cancer nonprofit organization, which Biden will head, will be based in either Wilmington, Del., or Washington, he said. Inside the White House, the organization is being referred to as the Biden Cancer Initiative, but the final name could be different. More details are expected in early February.

The organization won’t be affiliated with any particular cancer center — a decision designed to avoid the appearance of playing favorites among institutions that compete aggressively for grants, patients and top researchers. The group won’t make grants, though it will raise funds to support its own activities.

[Biden cites progress, hurdles in final "moonshot" report to Obama]

Talk of Biden’s post-White House plans has been circulating for some time. In September, he told the publication Stat that he would work on cancer issues for the rest of his life but didn’t provide details. In late December, the Cancer Letter, a trade publication, reported that he was planning to continue his moonshot work through a new institute or foundation and that he would work on foreign policy out of the University of Pennsylvania. On Tuesday, in a remark picked up by C-SPAN during the swearing-in ceremony for the Senate, Biden said he planned to “continue the cancer work” and would be “based out of Penn for foreign policy.”

In Wednesday’s interview, Biden said he would have posts at both Penn and the University of Delaware, his alma mater. Penn, he said, “wants me to advance their diplomatic profile around the world, and to work on policy and national security issues.” At Delaware, he will be working on domestic policy ranging from violence against women to the criminal justice system, he said. He declined to elaborate on the academic affiliations.

The White House Cancer Moonshot initiative was announced by President Obama in his State of the Union address this year. The initiative generated some skepticism among scientists who said that beating cancer was far more complicated than putting a man on the moon, and required vast increases in funding and a much greater understanding of the basic biology of the disease.

[Biden threatens funding cuts for researchers who don't report data]

Biden pressed ahead, traveling the country to meet with researchers and clinicians and repeatedly calling, sometimes angrily, for greater data sharing and collaboration. In September, the National Cancer Institute's blue-ribbon panel proposed 10 ways to speed progress against the disease. And late last year, Congress passed the 21st Century Cures Act, which provides almost $5 billion in new funding for the National Institutes of Health, including $1.8 billion for cancer moonshot efforts.

In the waning days of the administration, he continues to work on the moonshot. On Friday, he will host a meeting of vendors of electronic health records, physicians and patient advocates on how to make it easier for individual patients to get access to their medical records so they can share them with other doctors or provide the data to researchers.

<a href="https://www.washingtonpost.com/national/health-science/a-new-urgency-to-protect-survivors-of-childhood-cancer/2016/12/25/f29abb92-c0a8-11e6-afd9-f038f753dc29_story.html?utm_term=.376e49a80644">Researchers press efforts to help survivors of childhood cancer</a>

<a href="https://www.washingtonpost.com/national/health-science/hallucinogenic-drugs-relieved-cancer-patients-of-existential-distress/2016/11/30/fed60968-b1ab-11e6-8616-52b15787add0_story.html?utm_term=.6b2d41ff80f5">'Magic mushrooms' ingredient eases cancer patients' fear of death</a>

<a href="https://www.washingtonpost.com/news/to-your-health/wp/2016/10/27/in-a-first-u-s-trial-to-test-cuban-lung-cancer-vaccine/?utm_term=.3b821feedfd5">FDA approves trial to test Cuban lung-cancer vaccine</a>

Part of Wall Street Journal team that won the 1997 Pulitzer Prize for national reporting on AIDS 

Syracuse University, BS in journalism

Laurie McGinley covers health and medicine for The Washington Post. She focuses on the Food and Drug Administration as well as cancer research and treatment. She was previously The Post's health, science and environment editor. 

Laurie McGinley

The Washington Post

Health Care

Medical Mysteries

Science

Well+Being

Health

prism://prism.query/site,/health&limit=20

The Washington Post health section provides coverage and analysis of health, healthcare, nutrition and fitness news.